Literature DB >> 10701045

Streptoccocus pyogenes: a forgotten cause of severe community-acquired pneumonia.

C Birch1, J Gowardman.   

Abstract

We report a case of severe community-acquired pneumonia caused by Streptococcus pyogenes (Lancefield Group A streptoccocus) that was complicated by a streptococcal toxic shock syndrome. Although this micro-organism is an uncommon cause of community-acquired pneumonia, previously well individuals may be infected and the clinical course may be fulminant. A household contact was the likely point of infection. Invasive group A streptococcal disease continues to remain an important cause of morbidity and mortality in the community and therefore will continue to be encountered by intensive care physicians. Treatment of Group A streptococcal infection remains penicillin; however, clindamycin should be added in severe infection.

Entities:  

Mesh:

Year:  2000        PMID: 10701045     DOI: 10.1177/0310057X0002800117

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  4 in total

1.  Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001.

Authors:  Maria-Graciela Hollm-Delgado; Robert Allard; Pierre A Pilon
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

2.  Bacterial Pneumonia Caused by Streptococcus pyogenes Infection: A Case Report and Review of the Literature.

Authors:  Nobuhiro Akuzawa; Masahiko Kurabayashi
Journal:  J Clin Med Res       Date:  2016-09-29

3.  Pleural empyema and streptococcal toxic shock syndrome due to Streptococcus pyogenes in a healthy Spanish traveler in Japan.

Authors:  Tetsuya Sakai; Daisuke Taniyama; Saeko Takahashi; Morio Nakamura; Takashi Takahashi
Journal:  IDCases       Date:  2017-06-27

4.  Pneumatocele formation in a fatal adult pneumonia patient coinfected with Streptococcus pyogenes emm-type 3 and influenza A: a case report.

Authors:  Masahiro Sano; Aya Shimamoto; Nozomi Ueki; Motohiro Sekino; Hiroshi Nakaoka; Masahiro Takaki; Yoshiro Yamashita; Takeshi Tanaka; Konosuke Morimoto; Katsunori Yanagihara; Masahiro Nakashima; Kazuto Ashizawa; Koya Ariyoshi
Journal:  BMC Infect Dis       Date:  2020-11-26       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.